We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$34.3M
Cap. Flow
-$33.3M
Cap. Flow %
-33.2%
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.08M
2
UNH icon
UnitedHealth
UNH
+$4.05M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.82M
4
NVO
Novo Nordisk
NVO
+$2.52M
5
ABBV icon
AbbVie
ABBV
+$2.39M

Top Sells

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$4.32M
2
HRMY icon
Harmony Biosciences
HRMY
+$3.88M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$3.12M
4
EFC
Ellington Financial
EFC
+$2.6M
5
MTG icon
MGIC Investment
MTG
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 54.58%
2 Real Estate 7.4%
3 Industrials 5.96%
4 Financials 5.87%
5 Technology 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DDOG icon
201
Datadog
DDOG
$93.7B
$32.4K 0.03%
227
-40
-15% -$5.49K
MELI icon
202
Mercado Libre
MELI
$92.9B
$30.6K 0.03%
18
-3
-14% -$5.84K
WWD icon
203
Woodward
WWD
$23.3B
$29.8K 0.03%
179
-31
-15% -$5.3K
CRWD icon
204
CrowdStrike
CRWD
$202B
$28.7K 0.03%
336
-60
-15% -$4.99K
ESTC icon
205
Elastic
ESTC
$6.52B
$28.5K 0.03%
288
-51
-15% -$4.71K
ZS icon
206
Zscaler
ZS
$24.2B
$22.7K 0.02%
126
-22
-15% -$4.26K
SNOW icon
207
Snowflake
SNOW
$95.1B
$21.6K 0.02%
140
-24
-15% -$3.38K
EWO icon
208
iShares MSCI Austria ETF
EWO
$145M
$16.9K 0.02%
805
-3,946
-83% -$84.8K
SMCI icon
209
Super Micro Computer
SMCI
$15.4B
$12.8K 0.01%
421
-69
-14% -$2.51K
ACAD icon
210
Acadia Pharmaceuticals
ACAD
$4.3B
– –
-40,000
Closed -$615K
ACT icon
211
Enact Holdings
ACT
$6.48B
– –
-42,367
Closed -$1.54M
AGNC icon
212
AGNC Investment
AGNC
$12.5B
– –
-84,646
Closed -$885K
AMPH icon
213
Amphastar Pharmaceuticals
AMPH
$866M
– –
-30,000
Closed -$1.46M
APLS
214
DELISTED
Apellis Pharmaceuticals
APLS
– –
-47,500
Closed -$1.37M
ARGX icon
215
argenx
ARGX
$52.9B
– –
-4,500
Closed -$2.44M
ATEC icon
216
Alphatec Holdings
ATEC
$1.27B
– –
-370,000
Closed -$2.06M
AXSM icon
217
Axsome Therapeutics
AXSM
$11.4B
– –
-10,500
Closed -$944K
BCYC
218
Bicycle Therapeutics
BCYC
$290M
– –
-37,500
Closed -$849K
BMRN icon
219
BioMarin Pharmaceuticals
BMRN
$11.4B
– –
-32,500
Closed -$2.28M
CATX icon
220
Perspective Therapeutics
CATX
$333M
– –
-80,000
Closed -$1.07M
CGNX icon
221
Cognex
CGNX
$10.5B
– –
-15,000
Closed -$608K
CGON icon
222
CG Oncology
CGON
$6.19B
– –
-1,000
Closed -$37.7K
CHRS icon
223
Coherus Oncology
CHRS
$219M
– –
-330,000
Closed -$343K
CLDX icon
224
Celldex Therapeutics
CLDX
$2.78B
– –
-30,000
Closed -$1.02M
CYTK icon
225
Cytokinetics
CYTK
$10.7B
– –
-12,500
Closed -$660K
7 8
9
10 11

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.

  • AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
  • AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
  • AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
  • AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
  • AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
  • AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.